Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
De La Rue Share News (DLAR)
DLAR Share
Price
DLAR Share
News
DLAR Share
Chat
DLAR Share
Trades
DLAR
Live RNS
DLAR Share
Charts
DLAR Broker
Ratings
DLAR Directors
Deals
DLAR Financial
Diary
DLAR
Fundamentals
DLAR Short
Positions
DLAR
Media
DLAR Company
Research
DLAR Company
Timeline
- This share is currently suspended. It was suspended at a price of 130.00
- There is currently no data for DLAR
BUZZ-UK stocks: micro matters
** UK small-caps' valuation premium vs large-caps has almostvanished. Chart: http://link.reuters.com/byj92w
** Earnings growth forecasts for small-caps have collapsedvs start of year. Chart: http://link.reuters.com/tyj92w
** Profit warnings from handful of small companies this weakdeliver a wake-up call.
** Shanks Group and De la Rue latest to setout grim forecasts.
** Tate & Lyle warning on supply chain issuessparked a slew of downgrades while bar owner Mitchells & Butlersreported a weak quarter.
** Small- & mid-caps' outperformance vs FTSE100 likely to fade, mirroring similar moves in the U.S. . Chart: http://link.reuters.com/qyj92w
(RM: vikram.subhedar.thomsonreuters.com@reuters.net)
Latest DLAR News
- UK Earnings, Trading Statements Calendar - Next 7 Days
19 Nov 2019 - PRESS: Three Firms Explore Bid For De La Rue's Authentication Arm
11 Nov 2019 - TI Fluid Appoints Former De La Rue Boss Tim Cobbold To Board
5 Nov 2019 - LONDON MARKET MIDDAY: Caution Ahead Of US Interest Rate Guidance
30 Oct 2019 - UK WINNERS & LOSERS SUMMARY: ConvaTec Gains After Solid Organic Growth
30 Oct 2019 - De La Rue Shares Suffer Following Profit Warning Amid Transition
30 Oct 2019 - UPDATE 2-Pharma stocks lift FTSE 100 out of red
30 Oct 2019 - De La Rue tumbles after profit warning
30 Oct 2019
Related News
LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...
De La Rue News
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
PRESS: Three Firms Explore Bid For De La Rue's Authentication Arm
PRESS: Three Firms Explore Bid For De La Rue's Authentication Arm
TI Fluid Appoints Former De La Rue Boss Tim Cobbold To Board
TI Fluid Appoints Former De La Rue Boss Tim Cobbold To Board
LONDON MARKET MIDDAY: Caution Ahead Of US Interest Rate Guidance
LONDON MARKET MIDDAY: Caution Ahead Of US Interest Rate Guidance
UK WINNERS & LOSERS SUMMARY: ConvaTec Gains After Solid Organic Growth
UK WINNERS & LOSERS SUMMARY: ConvaTec Gains After Solid Organic Growth
De La Rue Shares Suffer Following Profit Warning Amid Transition
De La Rue Shares Suffer Following Profit Warning Amid Transition
UPDATE 2-Pharma stocks lift FTSE 100 out of red
* FTSE 100 up 0.3%, FTSE 250 down 0.3%* GSK, AstraZeneca among biggest boosts* Next Plc falls after Q3 update* Passport maker De La Rue hits lowest in...
De La Rue tumbles after profit warning
(Sharecast News) - Shares of De La Rue tumbled on Wednesday as the banknote printer warned on profits.
Follow the stocks
